Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 149 Breast Neoplasms 38 Prostatic Neoplasms 31 Insulin Resistance 30 Obesity 23 Endometrial Neoplasms 15 Neoplasms 14 Infertility 14 Colorectal Neoplasms 13 Pancreatic Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Anovulation 10 Lung Neoplasms 9 Neoplasm Metastasis 8 Hyperandrogenism 8 Glioblastoma 8 Diabetes Mellitus 8 Squamous Cell Carcinoma of Head and Neck 7 Metabolic Syndrome 7 Melanoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Head and Neck Neoplasms 5 Brain Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Rectal Neoplasms 4

Interventions

Ifosfamide 30 Methotrexate 27 Doxorubicin 25 Cyclophosphamide 24 Cisplatin 22 Filgrastim 18 Etoposide 17 Gemcitabine 16 Leucovorin 14 Magnetic Resonance Spectroscopy 11 Temozolomide 10 cabozantinib 9 apatinib 9 Specimen Handling 9 Carboplatin 9 fludarabine 8 X-Rays 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Docetaxel 8 Zoledronic Acid 7 Vincristine 7 Sirolimus 7 Radiotherapy 7 Phantoms, Imaging 7 Biopsy 7 Topotecan 6 Mesna 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteosarcoma × Metformin × Clear all

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡